Navellier & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.44M | Sell |
14,084
-64
| -0.5% | -$14.9K | 0.36% | 65 |
|
|
2025
Q4 | $2.93M | Sell |
14,148
-1,117
| -7% | -$221K | 0.33% | 75 |
|
|
2025
Q3 | $2.83M | Buy |
15,265
+881
| +6% | +$151K | 0.29% | 90 |
|
|
2025
Q2 | $2.2M | Hold |
14,384
| – | – | 0.27% | 94 |
|
|
2025
Q1 | $2.23M | Sell |
14,384
-881
| -6% | -$138K | 0.31% | 90 |
|
|
2024
Q4 | $2.21M | Sell |
15,265
-1,912
| -11% | -$296K | 0.26% | 94 |
|
|
2024
Q3 | $2.78M | Sell |
17,177
-881
| -5% | -$140K | 0.38% | 71 |
|
|
2024
Q2 | $2.64M | Sell |
18,058
-100
| -0.6% | -$14.9K | 0.31% | 85 |
|
|
2024
Q1 | $2.87M | Hold |
18,158
| – | – | 0.35% | 76 |
|
|
2023
Q4 | $2.85M | Buy |
18,158
+867
| +5% | +$133K | 0.43% | 71 |
|
|
2023
Q3 | $2.69M | Buy |
17,291
+15,591
| +917% | +$2.57M | 0.46% | 75 |
|
|
2023
Q2 | $281K | Buy |
1,700
+200
| +13% | +$32.3K | 0.05% | 225 |
|
|
2023
Q1 | $233K | Sell |
1,500
-100
| -6% | -$16.1K | 0.05% | 246 |
|
|
2022
Q4 | $283K | Buy |
1,600
+100
| +7% | +$17.3K | 0.06% | 219 |
|
|
2022
Q3 | $245K | Sell |
1,500
-200
| -12% | -$33.8K | 0.05% | 239 |
|
|
2022
Q2 | $302K | Hold |
1,700
| – | – | 0.06% | 232 |
|
|
2022
Q1 | $301K | Sell |
1,700
-100
| -6% | -$17K | 0.05% | 252 |
|
|
2021
Q4 | $308K | Sell |
1,800
-100
| -5% | -$16.4K | 0.04% | 259 |
|
|
2021
Q3 | $307K | Hold |
1,900
| – | – | 0.05% | 258 |
|
|
2021
Q2 | $313K | Buy |
1,900
+100
| +6% | +$16.6K | 0.05% | 245 |
|
|
2021
Q1 | $296K | Sell |
1,800
-242
| -12% | -$39.2K | 0.05% | 237 |
|
|
2020
Q4 | $321K | Hold |
2,042
| – | – | 0.06% | 215 |
|
|
2020
Q3 | $304K | Hold |
2,042
| – | – | 0.07% | 185 |
|
|
2020
Q2 | $287K | Hold |
2,042
| – | – | 0.07% | 185 |
|
|
2020
Q1 | $268K | Sell |
2,042
-400
| -16% | -$56.8K | 0.06% | 188 |
|
|
2019
Q4 | $356K | Buy |
2,442
+300
| +14% | +$40.7K | 0.06% | 224 |
|
|
2019
Q3 | $277K | Buy |
2,142
+200
| +10% | +$26.3K | 0.05% | 229 |
|
|
2019
Q2 | $270K | Buy |
1,942
+100
| +5% | +$13.8K | 0.04% | 223 |
|
|
2019
Q1 | $257K | Buy |
1,842
+100
| +6% | +$13.4K | 0.04% | 204 |
|
|
2018
Q4 | $225K | Sell |
1,742
-100
| -5% | -$13.9K | 0.04% | 198 |
|
|
2018
Q3 | $255K | Sell |
1,842
-575
| -24% | -$76.4K | 0.03% | 248 |
|
|
2018
Q2 | $293K | Sell |
2,417
-158
| -6% | -$19.7K | 0.04% | 247 |
|
|
2018
Q1 | $330K | Sell |
2,575
-1,880
| -42% | -$254K | 0.05% | 215 |
|
|
2017
Q4 | $623K | Sell |
4,455
-5,388
| -55% | -$750K | 0.12% | 162 |
|
|
2017
Q3 | $1.28M | Sell |
9,843
-3,573
| -27% | -$474K | 0.25% | 85 |
|
|
2017
Q2 | $1.77M | Sell |
13,416
-384
| -3% | -$49K | 0.27% | 108 |
|
|
2017
Q1 | $1.72M | Sell |
13,800
-400
| -3% | -$47.8K | 0.25% | 110 |
|
|
2016
Q4 | $1.64M | Sell |
14,200
-400
| -3% | -$46.2K | 0.27% | 111 |
|
|
2016
Q3 | $1.73M | Sell |
14,600
-729
| -5% | -$88.4K | 0.25% | 97 |
|
|
2016
Q2 | $1.86M | Buy |
+15,329
| New | +$1.74M | 0.28% | 64 |
|
|
2015
Q3 | – | Sell |
-2,066
| Closed | -$201K | – | 351 |
|
|
2015
Q2 | $201K | Sell |
2,066
-47
| -2% | -$4.71K | 0.02% | 341 |
|
|
2015
Q1 | $213K | Buy |
2,113
+152
| +8% | +$15.5K | 0.02% | 321 |
|
|
2014
Q4 | $205K | Sell |
1,961
-663
| -25% | -$69.9K | 0.01% | 309 |
|
|
2014
Q3 | $280K | Sell |
2,624
-23
| -0.9% | -$2.38K | 0.01% | 267 |
|
|
2014
Q2 | $277K | Sell |
2,647
-292,364
| -99% | -$29.6M | 0.01% | 270 |
|
|
2014
Q1 | $29M | Sell |
295,011
-17,362
| -6% | -$1.61M | 1.35% | 35 |
|
|
2013
Q4 | $28.6M | Sell |
312,373
-38,267
| -11% | -$3.53M | 1.29% | 38 |
|
|
2013
Q3 | $30.4M | Sell |
350,640
-6,291
| -2% | -$564K | 0.9% | 61 |
|
|
2013
Q2 | $30.6M | Buy |
+356,931
| New | +$30.3M | 1.46% | 36 |
|
Other funds holding JNJ
VCM
VPM
Navellier & Associates's JNJ Position: Q1 2026 in Review
Navellier & Associates reduced its Johnson & Johnson (JNJ) stake by 0.45% in Q1 2026, selling an estimated $14.9K and leaving 14,084 shares worth $3.44M. The position accounts for 0.36% of the portfolio, ranked #65.
Navellier & Associates first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $30.6M in Q2 2013. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Navellier & Associates held 14,084 shares of Johnson & Johnson worth $3.44M as of Q1 2026.
- Navellier & Associates sold 64 Johnson & Johnson shares in Q1 2026, an estimated $14.9K.
- Johnson & Johnson made up 0.36% of Navellier & Associates's portfolio in Q1 2026, its #65 holding.
- Navellier & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
- Navellier & Associates's Johnson & Johnson position peaked at $30.6M in Q2 2013.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.